Post-approval studies (Phase 4)Study completedNCT01585272
What this trial is testing
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
Who this might be right for
Alzheimer's Dementia
Novartis Pharmaceuticals 121